NVCR
NVCR
NASDAQ · Health Care

Novocure Ltd

$15.96
+0.27 (+1.72%)
As of Aug 8, 1:43 AM ET ·
Financial Highlights (FY 2026)
Revenue
697.47M
Net Income
-144,983,435
Gross Margin
74.5%
Profit Margin
-20.8%
Rev Growth
+6.8%
D/E Ratio
0.57
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 74.5% 74.5% 51.4% 51.4%
Operating Margin -23.5% -21.1% 23.4% 21.7%
Profit Margin -20.8% -19.8% 17.5% 18.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 697.47M 653.00M 251.06M 253.67M
Gross Profit 519.89M 486.74M 129.14M 130.49M
Operating Income -163,695,062 -137,932,361 58.84M 55.04M
Net Income -144,983,435 -122,165,613 43.96M 45.64M
Gross Margin 74.5% 74.5% 51.4% 51.4%
Operating Margin -23.5% -21.1% 23.4% 21.7%
Profit Margin -20.8% -19.8% 17.5% 18.0%
Rev Growth +6.8% +6.8% -1.9% +7.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 344.82M 344.82M 319.88M 342.35M
Total Equity 601.88M 601.88M 378.69M 362.47M
D/E Ratio 0.57 0.57 0.84 0.94
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -148,091,663 -131,717,142 70.91M 75.95M
Free Cash Flow 20.52M 25.20M